Company intelligence / Profile preview

AleraCare

Arizona, United States

Ownership: Private
Development stage: Other

Overview

AleraCare is a leading provider of infusion and specialty pharmacy services for patients with chronic and complex conditions. The company has expanded to over 35 ambulatory infusion centers in the U.S. and maintains a nearly 98.8% patient satisfaction rate. There is no evidence of investigational drug development or clinical trial outcomes reported.

Therapeutic areas: ImmunologyRare DiseasesGastroenterologyOncologyNeurology
Modalities: BiologicSmall moleculeProtein
Industry: Non-Academic Healthcare

Partnerships

Physician groupsPayorsPharmaceutical manufacturers

Beyond the preview

Go deeper on AleraCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AleraCare.

Explore the full profile